Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-27T04:21:47.746Z Has data issue: false hasContentIssue false
  • English
  • Français

Methicillin-Resistant Staphylococcus aureus in Two Tertiary-Care Centers in Jeddah, Saudi Arabia

Published online by Cambridge University Press:  02 January 2015

Tariq A. Madani ,
Nabeela A. Al-Abdullah ,
Ali A. Al-Sanousi ,
Tawfik M. Ghabrah ,
Shadia Z. Afandi  and
Huda A. Bajunid
Tariq A. Madani*
Affiliation:
Departments of Internal Medicine, Jeddah, Saudi Arabia King Abdulaz University Hospital, Jeddah, Saudi Arabia
Nabeela A. Al-Abdullah
Affiliation:
King Abdulaz University Hospital, Jeddah, Saudi Arabia
Ali A. Al-Sanousi
Affiliation:
Joint Program of Family and Community Medicine, Jeddah, Saudi Arabia
Tawfik M. Ghabrah
Affiliation:
Community Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Shadia Z. Afandi
Affiliation:
King Fahd Hospital, Jeddah, Saudi Arabia
Huda A. Bajunid
Affiliation:
King Fahd Hospital, Jeddah, Saudi Arabia
*
Department of Internal Medicine, King Abdulaziz University Hospital, PO Box 80215, Jeddah 21589, Saudi Arabia
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To review clinical experience with methicillin-resistant Staphylococcus aureus (MRSA) in tertiary-care hospitals in Jeddah, Saudi Arabia.

Design:

Retrospective review for the year 1998.

Setting:

Two tertiary-care hospitals.

Methods:

Results of MRSA-positive cultures of clinical specimens obtained as part of investigations for suspected infections were retrieved from the microbiology laboratories' records. Charts of patients were reviewed, with standardized data collection.

Results:

Of 673 S aureus isolates identified, 222 (33%, or 6.8 isolates/1,000 admissions) were MRSA Overall MRSA prevalence was 2% in 1988. Nosocomial acquisition occurred in 84.2% of cases. All age groups were affected, and 52% of patients had at least one comorbidity. MRSA prevalence was highest in the intensive care units (26.6% of all isolates), the medical wards (24.8%), and the surgical wards (19.8%). Seventy-three percent of isolates caused infection; the rest represented colonization. Surgical wounds (35.2%), the chest (29%), and central venous catheters (13%) were the most common sites of infection. Bacteremia occurred in 15.4% of patients. Local signs (84%) and fever (75.9%) were the most common clinical manifestations. Respiratory distress and septic shock occurred in 30.2% and 13.6% of cases, respectively. Of 162 patients with MRSA infection and 60 patients with MRSA colonization, 95.7% and 70% received antibiotics in the preceding 6 weeks, respectively (P<.0001). The total mortality of patients with MRSA infection was 53.7%: 36.4% as a result of MRSA infection and 17.3% as a result of other causes.

Conclusions:

The prevalence of MRSA is high and rapidly increasing in the two hospitals, as it is worldwide. Control measures to prevent die spread of MRSA in hospitals should continue, with reinforcement of hygienic precautions and development of policies to restrict the use of antibiotics.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 4 , April 2001 , pp. 211 - 216
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Boyce, JM. Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1989;3:901–913.CrossRefGoogle ScholarPubMed
2. Saravolatz, LD, Markowitz, N, Arking, L, Pohlod, D, Fisher, E. MRSA epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:11–16.Google Scholar
3. Moreno, F, Crisp, C, Jorgensen, JH, Patterson, JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995;21:1308–1312.Google Scholar
4. Pate, KR, Nolan, RL, Bannerman, TL, Feldman, S. Methicillin-resistant Staphylococcus aureus in the community. Lancet 1995;346:978.Google Scholar
5. Embil, J, Ramotar, K, Romance, L, Alfa, M, Conly, J, Cronk, S, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hasp Epidemiol 1994;15:646–651.Google Scholar
6. Herold, BC, Immergluck, LC, Maranan, MC, Lauderdale, DS, Gaskin, RE, Boyle-Vavra, S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593–598.Google Scholar
7. Boyce, JM. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1990;11:639–642.CrossRefGoogle ScholarPubMed
8. Voss, A, Milatovic, D, Wallrauch-Schwarz, C, Rosdahl, VT, Braveny, I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50–55.CrossRefGoogle ScholarPubMed
9. Oguri, T. The incidence and antimicrobial susceptibility of clinical isolates of MRSA from 1988 to 1990, from the results of 26 clinical laboratories in Tokyo and the surrounding area. Jap J Clin Med 1992;50:952–960.Google Scholar
10. Vincent, JL, Bihari, DJ, Suter, PM, Bruining, HA, White, J, Nicolas-Chanoin, MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639–644.Google Scholar
11. Vandenbroucke-Grauls, C. Management of methicillin-resistant Staphylococcus aureus in The Netherlands. Rev Med Microbiol 1998;9:109–116.Google Scholar
12. Hanifah, YA, Hiramatsu, K, Yokota, T. Characterization of methicillin-resistant Staphylococcus aureus associated with nosocomial infection in the University Hospital, Kuala Lumpur. J Hosp Infect 1992;21:15–28.Google Scholar
13. Gales, AC, Jones, RN, Pfaller, MA, Gordon, KA, Sader, HS. Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group. International Journal of Infectious Diseases 2000;4:75–84.Google Scholar
14. Geyid, A, Lemeneh, Y. The incidence of methicillin-resistant Staphylococcus aureus strains in clinical specimens in relation to their β-lactamase producing and multiple-drug resistance properties in Addis Ababa. Ethiop Med J 1991;29:149–161.Google Scholar
15. Hart, CA, Kariuki, S. Antimicrobial resistance in developing countries. BMJ 1998;317:647–650.Google Scholar
16. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard M2-A5. NCCLS: Villanova, PA; 1993.Google Scholar
17. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved standard M7-A3. NCCLS; Villanova, PA: 1993.Google Scholar
18. Panlilio, AL, Culver, DH, Gaynes, RP, Banerjee, S, Henderson, TS, Tolson, JS, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582–586.Google Scholar
19. Lowy, FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520–532.Google Scholar
20. Speller, DCE, Johnson, AP, James, D, Marples, RR, Charlett, A, George, RC. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997;350:323–325.Google Scholar
21. Mayor, S. England sets standards to reduce hospital acquired infection. BMJ 1999;319:1392.Google Scholar
22. Linnemann, CC, Moore, P, Staneck, JL, Pfaller, MA. Reemergence of epidemic methicillin-resistant Staphylococcus aureus in a general hospital associated with changing staphylococcal strains. Am J Med 1991;91(suppl 3B):238–344.Google Scholar
23. Nettleman, MD, Trilla, A, Fredrickson, M, Pfaller, MA. Assigning responsibility: using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus . Am J Med 1991;91(suppl 3B):228–232.Google Scholar
24. Layton, MC, Hierholzer, WJ, Patterson, JE. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol 1995;16:12–17.Google Scholar
25. Strausbaugh, LJ, Jacobson, C, Sewell, DL, Potter, S, Ward, TT. Methicillin-resistant Staphylococcus aureus in extended-care facilities: experiences in a Veterans Affairs nursing home and a review of the literature. Infect Control Hosp Epidemiol 1991;12:36–45.Google Scholar
26. Coello, R, Jimenez, J, Garcia, M, Arroyo, P, Minguez, D, Fernandez, C, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74–81.Google Scholar
27. Longfield, JN, Townsend, TR, Cruess, DF, Stephen, M, Bishop, C, Bolyard, E, et al. Methicillin-resistant Staphylococcus aureus (MRSA): risk and outcome of colonized vs infected patients. Infect Control 1985;6:445–450.Google Scholar
28. Myers, JP, Linnemann, CC. Bacteraemia due to methicillin-resistant Staphylococcus aureus . J Infect Dis 1982;145:532–536.CrossRefGoogle ScholarPubMed
29. French, GL, Cheng, AF, Ling, JM, Mo, P, Donnan, S. Hong Kong strains of methicillin-resistant and methiciUin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990;15:117–125.Google Scholar
30. Harbarth, S, Rutschmann, O, Sudre, P, Pittet, D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus . Arch Intern Med 1998;158:182–189.Google Scholar
31. Romero-Vivas, J, Rubio, M, Fernandez, C, Picazo, JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus . Clin Infect Dis 1995;21:1417–1423.Google Scholar
32. Conterno, LO, Wey, SB, Castelo, A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998;19:32–37.Google Scholar
33. Hiramatsu, K, Hanaki, H, Ino, T, Yabuta, K, Oguri, T, Tenover, FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135–136.Google Scholar
34. Hiramatsu, K, Aritaka, N, Hanaki, H, Kawasaki, S, Hosoda, Y, Hori, S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670–1673.Google Scholar
35. Smith, TL, Pearson, ML, Wilcox, KR, Cruz, C, Lancaster, MV, Robinson-Dunn, B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493–501.Google Scholar
36. Tenover, FC. Implications of vancomycin-resistant Staphylococcus aureus . J Hosp Infect 1999;43(suppl):3–7.CrossRefGoogle ScholarPubMed
37. Centers for Disease Control and Prevention. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR 1997;46:626–628.Google Scholar